Iberiabank Corp Has $840,000 Position in Walgreens Boots Alliance, Inc. (WBA)

Iberiabank Corp reduced its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 17.4% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,721 shares of the pharmacy operator’s stock after selling 2,254 shares during the quarter. Iberiabank Corp’s holdings in Walgreens Boots Alliance were worth $840,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Russell Investments Group Ltd. increased its position in Walgreens Boots Alliance by 72.9% in the 1st quarter. Russell Investments Group Ltd. now owns 482,962 shares of the pharmacy operator’s stock valued at $40,115,000 after acquiring an additional 203,635 shares during the period. Wellington Management Group LLP increased its position in Walgreens Boots Alliance by 5.9% in the 1st quarter. Wellington Management Group LLP now owns 32,846,862 shares of the pharmacy operator’s stock valued at $2,727,932,000 after acquiring an additional 1,824,300 shares during the period. Sumitomo Mitsui Asset Management Company LTD increased its position in Walgreens Boots Alliance by 9.3% in the 1st quarter. Sumitomo Mitsui Asset Management Company LTD now owns 75,821 shares of the pharmacy operator’s stock valued at $6,296,000 after acquiring an additional 6,462 shares during the period. Putnam FL Investment Management Co. increased its position in Walgreens Boots Alliance by 1,037.3% in the 1st quarter. Putnam FL Investment Management Co. now owns 74,860 shares of the pharmacy operator’s stock valued at $6,217,000 after acquiring an additional 68,278 shares during the period. Finally, Welch & Forbes LLC increased its position in Walgreens Boots Alliance by 4.8% in the 1st quarter. Welch & Forbes LLC now owns 96,882 shares of the pharmacy operator’s stock valued at $8,046,000 after acquiring an additional 4,453 shares during the period. Hedge funds and other institutional investors own 60.16% of the company’s stock.

In related news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction on Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total value of $218,305.44. Following the completion of the sale, the director now owns 19,151 shares in the company, valued at approximately $1,528,058.29. The transaction was disclosed in a filing with the SEC, which is available through this link. 13.50% of the stock is owned by corporate insiders.

Several equities analysts have recently issued reports on WBA shares. Morgan Stanley reiterated an “overweight” rating and set a $95.00 price target on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. BidaskClub upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Wednesday, August 30th. Royal Bank Of Canada started coverage on Walgreens Boots Alliance in a research report on Tuesday. They set an “outperform” rating and a $96.00 price target on the stock. Citigroup Inc. reiterated a “buy” rating on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. Finally, Loop Capital started coverage on Walgreens Boots Alliance in a research report on Thursday, August 24th. They set a “buy” rating and a $95.00 price target on the stock. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and fifteen have given a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $92.06.

Shares of Walgreens Boots Alliance, Inc. (NASDAQ WBA) traded down 1.00% during mid-day trading on Tuesday, hitting $81.77. The stock had a trading volume of 3,375,014 shares. The stock has a market capitalization of $87.50 billion, a price-to-earnings ratio of 20.65 and a beta of 1.26. Walgreens Boots Alliance, Inc. has a 12-month low of $75.18 and a 12-month high of $89.69. The stock’s 50-day moving average price is $81.35 and its 200-day moving average price is $81.89.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 EPS for the quarter, beating the consensus estimate of $1.30 by $0.03. The company had revenue of $30.12 billion during the quarter, compared to analysts’ expectations of $29.72 billion. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. The business’s revenue for the quarter was up 2.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.18 EPS. On average, equities analysts anticipate that Walgreens Boots Alliance, Inc. will post $5.00 EPS for the current fiscal year.

Walgreens Boots Alliance announced that its board has approved a share buyback plan on Thursday, June 29th that permits the company to repurchase $5.00 billion in shares. This repurchase authorization permits the pharmacy operator to buy up to 5.9% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s leadership believes its shares are undervalued.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 12th. Investors of record on Friday, August 18th were given a $0.40 dividend. The ex-dividend date was Wednesday, August 16th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.94%. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. Walgreens Boots Alliance’s dividend payout ratio is currently 40.30%.

TRADEMARK VIOLATION NOTICE: “Iberiabank Corp Has $840,000 Position in Walgreens Boots Alliance, Inc. (WBA)” was first posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this piece on another domain, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The original version of this piece can be read at https://ledgergazette.com/2017/09/19/iberiabank-corp-has-840000-position-in-walgreens-boots-alliance-inc-wba.html.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply